There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pfizer (PFE – Research Report) and Sagimet Biosciences, Inc. Class A (SGMT – R ...

According to InvestingPro analysis, the stock appears undervalued based on its ... with InvestingPro’s in-depth analysis and exclusive insights on PFE. Our Pro platform offers fair value estimates, ...

The most notable increase was in Bristol-Myers Squibb Co (NYSE:BMY), with an additional 14,342,846 shares, bringing the total ...

The yield on cost trajectory has also been great for ARE. Some long-term holders now exceed 20% yield on cost. This could either be a case of not having enough inside information [we the market], or a ...

ANGLE presents new data at EACR 2025 DEMONSTRATING DNA DUAL ANALYSIS FOR COMPREHENSIVE LIQUID BIOPSY PROFILINGPoster highlights ANGLE's combined CTC-DNA and ctDNA analysis revealing tumour ...

Common use cases of AI in the supply chain illustrate the benefits for companies of integrating AI into their operations. Attorneys supporting the supply chain function can similarly use generative AI ...

GSK stock is up 21.5% in six months, fueled by strong Specialty Medicines growth and a promising pipeline despite vaccine headwinds. Whether you're a value, growth ... Pharmaceutical stocks, including ...

The worst 2025 performer in the FTSE 100 has been hit by some fresh crises. Is it time for investors to abandon ship, or leap ...

Pierre, former White House Press Secretary, is advocating for a move beyond partisan politics. Her upcoming book, ...